Accredited vocational training within supported employment for Veterans: An evaluation of impact within Scotland’s Bravest Manufacturing Company

Abstract: Research with a small cohort of ex-Service personnel at Scotland’s Bravest Manufacturing Company (SBMC) – part of Royal British Legion Industries – has trialled and evaluated a progressive employment training scheme. The project embedded a training manager within SBMC and observed the experiences of ten ex-Service personnel trained over an 18-month period. The research was conducted by Glasgow Caledonian University and funded by Forces in Mind Trust. The training broke down several barriers to work readiness for the ex-Service personnel who took part in the programme. For example, many reported that the military qualifications they had gained during their time in the Armed Forces were not recognised as transferable to civilian employment. However, through embedding a training manager, who implemented a range of accredited qualifications, they felt that their skills were validated and recognised and it prepared them for further employment through learning new skills. Whilst providing the tangible benefit of attaining civilian qualifications, this also helped the ex-Service personnel gain confidence in the workplace, knowing that they had qualifications that could be used outside the military should they wish to seek other employment. All of the participants of the study were on fixed-term contracts at the beginning of the project, with 8 of the 10 joining SBMC on a permanent basis by its conclusion. SBMC’s Progressive Employment Training Programme has continued to train veterans to work at their factory in Erskine, Renfrewshire.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P